The following government grants in the FederalGrants.com database contain the term small business in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Clinical, Behavioral, and Physiological Studies of Open- and Closed-loop Platforms: Toward Personalized, Fully Automated, Accessible Systems (R01 Clinical Trial Required) |
93.847 |
RFA-DK-22-020 |
| NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional) |
93.398 |
RFA-CA-22-050 |
| Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional) |
93.279 |
PAR-22-200 |
| AHRQ National Research Service Award (NRSA) Institutional Research Training Grant (T32) |
93.225 |
RFA-HS-22-010 |
| BRAIN Initiative: Engineering and optimization of molecular technologies for functional dissection of neural circuits (UM1 Clinical Trial Not Allowed) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-MH-22-245 |
| Environmental influences on Child Health Outcomes (ECHO) Measurement Core (U24) Clinical Trial Not Allowed |
93.113, 93.121, 93.213, 93.233, 93.242, 93.273, 93.279, 93.307, 93.310, 93.350, 93.361, 93.837, 93.838, 93.839, 93.840, 93.847, 93.853, 93.855, 93.865, 93.866, 93.879 |
RFA-OD-22-020 |
| Time-Sensitive Opportunities for Health Research (R61/R33 Clinical Trial Not Allowed) |
93.273, 93.279, 93.307, 93.313, 93.361, 93.399, 93.846, 93.865 |
PAR-22-233 |
| Limited Competition: Environmental influences on Child Health Outcomes (ECHO) Pregnancy and Pediatric Cohort Study Sites. Clinical Trial Not Allowed (UG3/UH3) |
93.113, 93.121, 93.213, 93.233, 93.242, 93.273, 93.279, 93.307, 93.310, 93.313, 93.350, 93.361, 93.399, 93.837, 93.838, 93.839, 93.840, 93.847, 93.853, 93.855, 93.865, 93.866, 93.879 |
RFA-OD-22-018 |
| Conducting Public Health Research with Universities in Thailand |
93.326 |
RFA-GH-23-003 |
| Environmental influences on Child Health Outcomes (ECHO) Data Analysis Center (U24) Clinical Trial Not Allowed |
93.113, 93.121, 93.213, 93.233, 93.242, 93.273, 93.279, 93.307, 93.310, 93.350, 93.361, 93.837, 93.838, 93.839, 93.840, 93.847, 93.853, 93.855, 93.865, 93.866, 93.879 |
RFA-OD-22-022 |
| Limited Competition: Environmental influences on Child Health Outcomes (ECHO) Cohort Study Sites for Pediatric Follow Up. Clinical Trial Not Allowed (UG3/UH3) |
93.113, 93.121, 93.213, 93.233, 93.242, 93.273, 93.279, 93.307, 93.310, 93.313, 93.350, 93.361, 93.399, 93.837, 93.838, 93.839, 93.840, 93.847, 93.853, 93.855, 93.865, 93.866, 93.879 |
RFA-OD-22-019 |
| Environmental influences on Child Health Outcomes (ECHO) Coordinating Center (U2C) (Clinical Trial Not Allowed) |
93.113, 93.121, 93.213, 93.233, 93.242, 93.273, 93.279, 93.307, 93.310, 93.350, 93.361, 93.837, 93.838, 93.839, 93.840, 93.847, 93.853, 93.855, 93.865, 93.866, 93.879 |
RFA-OD-22-021 |
| HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R21 Clinical Trial Not Allowed) |
93.242, 93.273, 93.279, 93.853, 93.865 |
RFA-HD-23-031 |
| HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R21 Basic Experimental Studies with Humans Required) |
93.242, 93.273, 93.279, 93.853, 93.865 |
RFA-HD-23-033 |
| HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R01 Clinical Trial Not Allowed) |
93.242, 93.273, 93.279, 93.853, 93.865 |
RFA-HD-23-030 |
| Environmental influences on Child Health Outcomes (ECHO) Laboratory Core (U24) Clinical Trial Not Allowed |
93.113, 93.121, 93.213, 93.233, 93.242, 93.273, 93.279, 93.307, 93.310, 93.350, 93.361, 93.837, 93.838, 93.839, 93.840, 93.847, 93.853, 93.855, 93.865, 93.866, 93.879 |
RFA-OD-22-016 |
| Open Competition: Environmental influences on Child Health Outcomes (ECHO) Pregnancy Cohort Study Sites. Clinical Trial Not Allowed (UG3/UH3) |
93.113, 93.121, 93.213, 93.233, 93.242, 93.273, 93.279, 93.307, 93.310, 93.313, 93.350, 93.361, 93.399, 93.837, 93.838, 93.839, 93.840, 93.847, 93.853, 93.855, 93.865, 93.866, 93.879 |
RFA-OD-22-017 |
| HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R01 Basic Experimental Studies with Humans Required) |
93.213, 93.242, 93.273, 93.853, 93.865 |
RFA-HD-23-032 |
| CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed) |
93.853, 93.855 |
PAR-23-027 |
| The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed) |
93.396 |
PAR-22-234 |
| Blood Brain Barrier Response to Antibodies Targeting Beta-Amyloid (R01 - Clinical Trial Not Allowed) |
93.853, 93.866 |
PAR-22-235 |
| Grants to Support New Investigators in Conducting Research Related to Understanding Polydrug Use Risk and Protective Factors |
93.136 |
RFA-CE-23-002 |
| NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed) |
93.866 |
PAR-22-227 |
| Catalyst Award for Early-Stage Investigators (ESIs) Pursuing Research on HIV Comorbidities, Coinfections, and Complications (DP1- Clinical Trial Optional) |
93.233, 93.398, 93.837, 93.838, 93.839, 93.840, 93.847, 93.865 |
PAR-23-024 |
| NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Independent Clinical Trial Not Allowed) |
93.866 |
PAR-22-226 |
| NICHD Research Education Programs (R25 Clinical Trial Not Allowed) |
93.350, 93.865 |
PAR-22-224 |
| Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult Cancers (UG3/UH3 Clinical Trial Required) |
93.395 |
RFA-CA-22-028 |
| Optimization of Genome Editing Therapeutics for Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) (U01 - Clinical Trials Not Allowed) |
93.853, 93.866 |
RFA-NS-23-017 |
| Funding Opportunity in Support of the Hydrogen Shot and a University Research Consortium on Grid Resilience |
81.087 |
DE-FOA-0002792 |
| Drug Induced Liver Injury Network (DILIN) Clinical Centers (U01 - Clinical Trial Optional) |
93.847 |
RFA-DK-22-013 |
| Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical Trial Required) |
93.395 |
RFA-CA-22-029 |
| Cancer Adoptive Cellular Therapy Network (Can-ACT) Coordinating Center (U24 Clinical Trial Not Allowed) |
93.395 |
RFA-CA-22-030 |
| REsearch Across Complementary and Integrative Health Institutions (REACH) Virtual Resource Centers (U24 Clinical Trial Not Allowed) |
93.213 |
RFA-AT-23-007 |
| Physiomimetics and Organoids for Reproductive Health (R01 Clinical Trial Not Allowed) |
93.865 |
RFA-HD-23-024 |
| The Incentivize Learning Activity - AMENDMENT 01 |
98.001 |
72066922RFA00004 |
| HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed) |
93.121, 93.213, 93.273, 93.286, 93.393, 93.395, 93.846, 93.853, 93.865, 93.866, 93.867 |
RFA-EB-22-002 |
| Maintaining Immunity after Immunization (U01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-22-055 |
| Physiomimetics and Organoids for Reproductive Health (R21 Clinical Trial Not Allowed) |
93.865 |
RFA-HD-23-025 |
| Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) |
93.279, 93.855 |
RFA-DA-23-056 |
| The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) |
93.398 |
RFA-CA-22-041 |
Search Results 1961-2000 of 21019
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 [Next] |
